Metformin Extended Release Oral Tablet
Sponsors
Weill Medical College of Cornell University, West Side Institute for Science and Education, Joslin Diabetes Center, Trisha Wise-Draper, Woman's
Conditions
Breast Cancer StageCardiac FibrosisChronic Fatigue SyndromeHIV SeropositivityHead and Neck Squamous Cell CarcinomaHyperemesis GravidarumInsulin ResistanceLong COVID-19 Syndrome
Phase 2
Oral Hypoglycemic Therapy for Monogenic Variant Carriers of the Joslin Medalist Study
CompletedNCT04409795
Start: 2021-08-26End: 2024-12-31Updated: 2025-02-24
Combining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer Patients
Active, not recruitingNCT04414540
Start: 2020-08-31End: 2025-12-31Target: 20Updated: 2025-12-19
A Pilot Study of Metformin to Reduce Cerebrovascular Dysfunction in Participants With HIV and Metabolic Syndrome.
CompletedNCT05571319
Start: 2022-08-11End: 2025-03-28Updated: 2025-10-06
Hyperemesis Gravidarum Risk Reduction With Metformin
Not yet recruitingNCT07129473
Start: 2026-01-31End: 2031-01-31Target: 224Updated: 2025-12-11
Phase 3
Phase 4
Trial of an Intervention to Improve Metformin Persistence and Adherence
CompletedNCT03467763
Start: 2018-02-09End: 2020-08-01Updated: 2020-12-07
Tolerance & Responsiveness Improvement for Metformin (TRIM)
CompletedNCT03670043
Start: 2019-03-19End: 2021-08-15Updated: 2021-09-10
Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer
WithdrawnNCT04741204
Start: 2022-09-30End: 2022-09-30Updated: 2023-07-06
Metformin Use in Cardiac Fibrosis in PAI-1 Deficiency
Active, not recruitingNCT05317806
Start: 2022-10-10End: 2027-10-31Target: 15Updated: 2024-11-06